Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;69(2):176-194.
doi: 10.1099/jmm.0.001141. Epub 2020 Jan 24.

Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses

Affiliations
Review

Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses

Warren P Herridge et al. J Med Microbiol. 2020 Feb.

Abstract

Klebsiella spp. are commensals of the human microbiota, and a leading cause of opportunistic nosocomial infections. The incidence of multidrug resistant (MDR) strains of Klebsiella pneumoniae causing serious infections is increasing, and Klebsiella oxytoca is an emerging pathogen. Alternative strategies to tackle infections caused by these bacteria are required as strains become resistant to last-resort antibiotics such as colistin. Bacteriophages (phages) are viruses that can infect and kill bacteria. They and their gene products are now being considered as alternatives or adjuncts to antimicrobial therapies. Several in vitro and in vivo studies have shown the potential for lytic phages to combat MDR K. pneumoniae infections. Ready access to cheap sequencing technologies has led to a large increase in the number of genomes available for Klebsiella-infecting phages, with these phages being heterogeneous at the whole-genome level. This review summarizes our current knowledge on phages of Klebsiella spp. and highlights technological and biological issues relevant to the development of phage-based therapies targeting these bacteria.

Keywords: Klebsiella oxytoca; Klebsiella pneumoniae; antimicrobial resistance; phage therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Phylogenetic placement of dsDNA Klebsiella phages within the order Caudovirales. Placement of 109 genomes (Table 1) within ViPTree version 1.9 [164] was checked on 6 August 2019. Those sequences (n=84) that clustered together in groups of three or more were analysed with their nearest phylogenetic relatives using ViPTreeGen v1.1.2 (--ncpus 8 --method ‘bioinj’) and a non-redundant set of genomes (a fasta file of input sequences, https://doi.org/10.6084/m9.figshare.11635965.v1; newick-format file, https://doi.org/10.6084/m9.figshare.11635953.v1) to generate the tree shown (annotated using https://itol.embl.de and Adobe Illustrator). The taxonomy of the phages was checked via https://talk.ictvonline.org/taxonomy/ (release 2018b); accepted species names are written in italics. A phylogenetic tree showing the placement of the remaining 25 Klebsiella genomes within ViPTree version 1.9 is available (https://doi.org/10.6084/m9.figshare.11635962.v1; genome list, https://doi.org/10.6084/m9.figshare.11635950.v1; newick-format file, https://doi.org/10.6084/m9.figshare.11635971.v1) as Supplementary Material. Since the trees in this figure and the Supplementary Material were created, genomes for the following phages have been published: vB_KpnS_FZ10, Shelby, Sin4, Skenny, Sweeny and Sanco (Webervirus); vB_KpnP_FZ12 (Przondovirus); vB_KpnM_FZ14 (Jedunavirus); vB_KpnS_FZ41 and KpGranit (Sugarlandvirus); Patroon (Teseptimavirus); KpCHEMY26 (Ithacavirus); Magnus (genus unknown); Mulock (related to Brunovirus); Marfa (genus unknown). Additional information for these phages is available in Table 1.

Similar articles

Cited by

References

    1. Podschun R, Ullmann U. Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors. Clin Microbiol Rev. 1998;11:589–603. doi: 10.1128/CMR.11.4.589. - DOI - PMC - PubMed
    1. Shon AS, Bajwa RPS, Hypervirulent RTA. hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 2013;4:107–118. - PMC - PubMed
    1. World Health Organization Global antimicrobial resistance surveillance system (glass) report. early implementation 2017-2018. 2018.
    1. Chong Y, Yakushiji H, Ito Y, Kamimura T. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur J Clin Microbiol Infect Dis. 2011;30:83–87. doi: 10.1007/s10096-010-1057-1. - DOI - PubMed
    1. Khan E, Schneiders T, Zafar A, Aziz E, Parekh A, et al. Emergence of CTX-M Group 1-ESBL producing Klebsiella pneumonia from a tertiary care centre in Karachi, Pakistan. J Infect Dev Ctries. 2010;4:472–476. doi: 10.3855/jidc.674. - DOI - PubMed